1. Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF‐A/caveolin‐1/PV‐1 signaling pathway. Issue 4 (23rd February 2022) Authors: Locatelli, Monica; Zoja, Carlamaria; Conti, Sara; Cerullo, Domenico; Corna, Daniela; Rottoli, Daniela; Zanchi, Cristina; Tomasoni, Susanna; Remuzzi, Giuseppe; Benigni, Ariela Journal: Journal of pathology Issue: Volume 256:Issue 4(2022) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗